Recipharm to present at the 2020 UBS Virtual Global Healthcare Conference

Recipharm, a leading Contract Development and Manufacturing Organisation (CDMO), announced today that CEO Thomas Eldered and CFO Tobias Hägglöv will present at the 2020 UBS Virtual Global Healthcare Conference on Monday, May 18, 2020 at 8:20 a.m. ET | 2:20 p.m. CET.

A live webcast of the presentations will be accessible through the Company’s website at www.recipharm.com/events/virtual-global-healthcare-conference and will be available for replay following the event.

For more information, please contact:
ir@recipharm.com, telephone: +46 8 602 52 00

About Recipharm
Recipharm is a leading Contract Development and Manufacturing Organisation (CDMO) in the pharmaceutical industry employing almost 9,000 employees. Recipharm offers manufacturing services of pharmaceuticals in various dosage forms, production of clinical trial material and APIs, pharmaceutical product development and development and manufacturing of medical devices. Recipharm manufactures several hundred different products to customers ranging from big pharma to smaller research and development companies. Recipharm’s annual turnover is approximately SEK 11 billion. The company operates development and manufacturing facilities in France, Germany, India, Israel, Italy, Portugal, Spain, Sweden, the UK and the US and is headquartered in Stockholm, Sweden. The Recipharm B-share (RECI B) is listed on Nasdaq Stockholm.

For more information on Recipharm and our services, please visit www.recipharm.com

Recipharm AB (publ)
Corporate identity number 556498-8425
Address Box 603, SE-101 32 Stockholm, Sweden, Telephone +46 8 602 52 00
www.recipharm.com

Tags: